Roger Mysliwiec

Roger Mysliwiec

New Zealand New ZealanddoctorMale5.0Global Dominance: 0.00%

Dr. Roger Mysliwiec is the director of a New Zealand Eating Disorders Clinic and a prominent voice in discussions surrounding the implications of GLP-1 weight-loss drugs like Ozempic and Wegovy. He has expressed concerns about the aggressive marketing of these medications, particularly on social media, and their potential to exacerbate eating disorders among vulnerable populations. Mysliwiec highlights the need for careful prescription and management of these drugs, emphasizing the risks associated with unregulated use and the alarming trends in weight-loss marketing.

Power224
Reach5,141

Country presence

Recent news mentions

Dr. Roger Mysliwiec is concerned about the risks of weight loss drugs that have not been fully considered.

Weight loss drug for the wealthy surges in Auckland but experts warn of health concerns
The New Zealand Herald – country’s largest newspaper, est. 1863·New ZealandNew Zealand· 2026-09-25
5.0

Dr Roger Mysliwiec says GLP1 drugs were being 'pushed very strongly' for weight loss on social media.

Are weight-loss drugs like Ozempic causing eating disorders with ‘sinister’ marketing?
The New Zealand Herald – country’s largest newspaper, est. 1863·New ZealandNew Zealand· 2025-10-18
5.0